MS

FDA Grants Breakthrough Therapy Designation to Sanofi’s Tolebrutinib for Non-Relapsing Secondary Progressive Multiple Sclerosis
Pharm Exec
Mon, 12/16/24 - 11:35 am
Sanofi
tolebrutinib
MS
non-relapsing secondary progressive MS
FDA
Teva slapped with €463M fine over accusations it stymied Copaxone competition in Europe
Fierce Pharma
Thu, 10/31/24 - 10:42 pm
Teva Pharmaceutical
competition
Europe
legal
Copaxone
MS
Teva hands over $450M to resolve kickback lawsuits involving MS drug Copaxone and generics
Fierce Pharma
Fri, 10/11/24 - 10:19 am
Teva Pharmaceutical
Copaxone
kickbacks
MS
multiple sclerosis
legal
Denali-Sanofi scraps mid-stage study for multiple sclerosis drug
Reuters
Thu, 10/10/24 - 11:20 pm
Denali
Sanofi
clinical trials
multiple sclerosis
MS
oditrasertib
City of Baltimore sues Biogen over allegedly paying PBMs to stave off Tecfidera generic competition
Medical Marketing and Media
Wed, 09/25/24 - 10:19 pm
Biogen
Baltimore
legal
PBMs
generics
competition
MS
Tecfidera
Sanofi’s eyes approval after MS therapy slows disease progression by 31%
Clinical Trials Arena
Sun, 09/22/24 - 09:42 pm
Sanofi
tolebrutinib
MS
multiple sclerosis
FDA
Sanofi lifts lid on MS data behind tolebrutinib’s mixed phase 3 scorecard, plans ‘24 approval filings
Fierce Biotech
Fri, 09/20/24 - 10:15 am
Sanofi
tolebrutinib
clinical trials
MS
multiple sclerosis
Roche doubles down with another subcutaneous FDA nod, this one for MS star Ocrevus
Fierce Pharma
Sun, 09/15/24 - 06:17 pm
Roche
Genentech
Ocrevus
MS
Ocrevus Zunovo
Teva faces EU fine for disparaging rival multiple sclerosis medicine, sources say
Reuters
Tue, 09/10/24 - 04:22 pm
Teva Pharmaceutical
Europe
MS
multiple sclerosis
generics
Copaxone
antitrust
Roche trumpets new fenebrutinib data in relapsing MS
Pharmaphorum
Wed, 09/4/24 - 11:25 am
Roche
clinical trials
fenebrutinib
MS
relapsing multiple sclerosis
Sanofi finds a silver lining in mixed MS drug results
BioPharma Dive
Tue, 09/3/24 - 05:50 pm
Sanofi
tolebrutinib
MS
multiple sclerosis
clinical trials
Sanofi's mixed fortunes in MS drug trials has market focus on win
Reuters
Mon, 09/2/24 - 12:11 pm
Sanofi
multiple sclerosis
MS
clinical trials
tolebrutinib
First bispecific CAR-T therapy for MS receives green light from FDA to start phase 1
Biopharma Reporter
Thu, 08/22/24 - 11:15 am
ImmPACT Bio
CAR-T
MS
multiple sclerosis
FDA
clinical trials
A potential MS ‘game changer’ could bring more safety to the table — even against viruses
Pharma Voice
Tue, 08/13/24 - 11:28 am
Immunic
vidofludimus calcium
MS
multiple sclerosis
FDA grants IND clearance for TG Therapeutics’ trial of multiple sclerosis treatment
Clinical Trials Arena
Mon, 08/12/24 - 11:25 am
Precision Biosciences
TG Therapeutics
FDA
azer-cel
progressive MS
MS
clinical trials
FDA grants IND clearance for Indapta’s multiple sclerosis treatment trial
Clinical Trials Arena
Wed, 08/7/24 - 11:40 am
Indapta
FDA
multiple sclerosis
MS
clinical trials
IDP-023
Peloton’s Robin Arzón shines light on MS at Genentech-backed panel
Medical Marketing and Media
Fri, 08/2/24 - 11:41 am
Genentech
pharma marketing
MS
multiple sclerosis
Sanofi reports findings from Phase II relapsing MS treatment trial
Clinical Trials Arena
Mon, 07/1/24 - 11:00 am
Sanofi
frexalimab
relapsing multiple sclerosis
MS
clinical trials
Forbion-backed biotech Progentos debuts with $65M for MS drug
BioPharma Dive
Mon, 05/20/24 - 05:50 pm
Progentos
Forbion
MS
multiple sclerosis
funding
Royalty Pharma pays startup $525M for stake in Sanofi MS drug
BioPharma Dive
Thu, 05/9/24 - 07:13 pm
Sanofi
Royalty Pharma
MS
ImmuNext
frexalimab

Pages